E-LIB Suche - Ergebnisse für: G. Gravis

1

A phase II study of retifanlimab, a humanized anti-PD-1 mon..:

Di Giacomo, A.M. ; Schenker, M. ; Medioni, J....
ESMO Open. 9 (2024) 3 - p. 102387 , 2024

Link: https://doi.org/10.1016/..

2

Gastrointestinal metastases in renal cell carcinoma: A retr..:

Carneiro, F. ; Vinceneux, A. ; Larroquette, M....
European Journal of Cancer. 199 (2024) - p. 113534 , 2024

Link: https://doi.org/10.1016/..

3

Oncological outcomes of chemohyperthermia with HIVEC for BC..:

Pignot, G. ; Baboudjian, M. ; Masson-Lecomte, A....
European Urology Open Science. 57 (2023) - p. S295 , 2023

Link: https://doi.org/10.1016/..

4

28P 3-year follow-up analysis of disease-free survival in C..:

Stenner-Liewen, F. ; Galsky, M. ; Bajorin, D....
Immuno-Oncology and Technology. 20 (2023) - p. 100497 , 2023

Link: https://doi.org/10.1016/..

5

Urachal carcinoma: a large retrospective multicentric study..:

Guerin, M. ; Miran, C. ; Colomba, E....
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

6

POSC134 Cost-Effectiveness Analysis of Innovative Therapy f..:

Pelloux-Prayer, R ; Schiele, P ; Oudard, S...
Value in Health. 25 (2022) 1 - p. S113 , 2022

Link: https://doi.org/10.1016/..

7

Efficacy and correlative analyses of avelumab plus axitinib..:

Choueiri, T.K. ; Larkin, J. ; Pal, S....
ESMO Open. 6 (2021) 3 - p. 100101 , 2021

Link: https://doi.org/10.1016/..

8

Erratum to 'Efficacy and correlative analyses of avelumab p..:

Choueiri, T.K. ; Larkin, J. ; Pal, S....
ESMO Open. 6 (2021) 4 - p. 100177 , 2021

Link: https://doi.org/10.1016/..

9

Nephrectomy after complete response to immune checkpoint in..:

Pignot, G. ; Thiery-Vuillemin, A. ; Walz, J....
European Urology. 79 (2021) - p. S892-S893 , 2021

Link: https://doi.org/10.1016/..

10

Randomized phase III trial of dose-dense MVAC or GC as peri..:

Pfister, C. ; Gravis, G. ; Flechon, A....
European Urology Open Science. 19 (2020) - p. e108-e109 , 2020

Link: https://doi.org/10.1016/..

11

Nephrectomy after complete response to immune checkpoint in..:

Pignot, G. ; Thiery-Vuillemin, A. ; Walz, J....
European Urology Open Science. 19 (2020) - p. e1264 , 2020

Link: https://doi.org/10.1016/..

12

Pembrolizumab (pembro) plus olaparib in docetaxel-pretreate..:

Piulats, J.M. ; Yu, E. ; Gravis, G....
European Urology Open Science. 19 (2020) - p. e873-e874 , 2020

Link: https://doi.org/10.1016/..

13

KEYNOTE-365 cohort c updated results: Pembrolizumab (pembro..:

Feyerabend, S. ; Berry, W. ; Fong, P....
European Urology Open Science. 19 (2020) - p. e875-e876 , 2020

Link: https://doi.org/10.1016/..

14

CtDNA as a predictor of outcome in patients treated with ne..:

Powles, T ; Szabados, B ; Castellano, D...
Urologic Oncology: Seminars and Original Investigations. 38 (2020) 12 - p. 911 , 2020

Link: https://doi.org/10.1016/..

15

KEYNOTE-365 cohort B updated results: Pembrolizumab (pembro..:

Gravis, G. ; Kolinsky, M. ; Mourey, L....
European Urology Open Science. 19 (2020) - p. e871-e872 , 2020

Link: https://doi.org/10.1016/..